OTC: IDRSF - Idorsia Ltd

Lønnsomhet i seks måneder: -59.46%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Idorsia Ltd

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Idorsia Ltd

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.

flere detaljer
Its products include PIVLAZ (clazosentan), available in 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage securing; and QUVIVIQ (daridorexant), available in 25 and 50 mg, for the treatment of adult patients with insomnia. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and Hoffman-La Roche Inc. to develop and market compounds in the field of cancer immunotherapy. It also has a collaboration with Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase II clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета chf
Сайт https://www.idorsia.com
Цена ао 1.15
Prisendring per dag: 0% (1.05)
Prisendring per uke: -19.85% (1.31)
Prisendring per måned: +40% (0.75)
Prisendring over 3 måneder: +50% (0.7)
Prisendring over seks måneder: -59.46% (2.59)
Prisendring per år: -60.23% (2.64)
Prisendring over 3 år: -94.21% (18.15)
Prisendring over 5 år: -96.18% (27.5)
Prisendring siden begynnelsen av året: +50% (0.7)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 2.3 6
P/BV -0.3623 0
P/E 0 0
EV/EBITDA -2.69 0
Total: 4.38

Effektivitet

Navn Betydning Karakter
ROA, % -59.58 0
ROE, % 30.75 9
Total: 3.17

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -2.17 10
Total: 9.2

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 539.77 10
Lønnsomhet Ebitda, % -44.99 0
Lønnsomhet EPS, % -55.07 0
Total: 3
Flere detaljer

Institusjoner Volum Dele, %
Fidelity Select Portfolios - Biotechnology 4866770 2.58
Smallcap World Fund 2270994 1.2
Vanguard International Stock Index-Total Intl Stock Indx 1627551 0.86
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 958060 0.51
iShares Core MSCI EAFE ETF 628695 0.33
Fidelity Growth Company Fund 623409 0.33
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 479318 0.25
iShares MSCI EAFE Small Cap ETF 426739 0.23
Vanguard International Stock Index-Vanguard European Stock Index 252174 0.13
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 238962 0.13



Veileder Stillingstittel Betaling Fødselsår
Mr. Jean-Paul Clozel M.D. CEO & Chairman of the Board 956.86k 1955 (70 år)
Dr. Martine Clozel Executive VP & Chief Scientific Officer N/A 1955 (70 år)
Mr. Andrew C. Weiss Senior VP and Head of Investor Relations & Corporate Communications N/A 1968 (57 år)
Mr. Julien Gander L.L.M. Senior VP, Group General Counsel & Company Secretary N/A 1979 (46 år)
Mr. Alexander Khatuntsev Senior VP & Head of Global Human Resources N/A 1978 (47 år)
Dr. Guy Braunstein M.D. Executive VP & Chief Medical Officer N/A 1956 (69 år)
Mr. Olivier Lambert Senior VP & Head of Technical Operations N/A 1966 (59 år)
Mr. Markus A. Riederer Senior VP & Head of Drug Discovery Biology N/A 1962 (63 år)
Mr. Alberto Gimona M.D. Executive VP & Head of Global Clinical Development N/A 1960 (65 år)
Mr. Andre C. Muller Executive VP & CFO 1963 (62 år)

Adresse: Switzerland, Allschwil, Hegenheimermattweg 91 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.idorsia.com